$ATMV
AlphaVest Acquisition Corp.

2024 Q4 Form 10-Q Financial Statement

#000149315224046848 Filed on November 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $182.6K
YoY Change -8.71%
Operating Profit -$182.6K
YoY Change -8.17%
Interest Expense $684.6K
YoY Change -27.94%
% of Operating Profit
Other Income/Expense, Net $684.6K
YoY Change 17585.38%
Pretax Income $502.0K
YoY Change -33.94%
Income Tax
% Of Pretax Income
Net Earnings $502.0K
YoY Change -33.59%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.07
COMMON SHARES
Basic Shares Outstanding 7.006M shares 7.006M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.100K
YoY Change -88.17%
Cash & Equivalents $7.095K
Short-Term Investments
Other Short-Term Assets $21.40K
YoY Change -57.2%
Inventory
Prepaid Expenses $21.40K
Receivables
Other Receivables
Total Short-Term Assets $28.49K
YoY Change -72.98%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $53.01M
YoY Change -27.39%
Other Assets $55.00K
YoY Change
Total Long-Term Assets $53.07M
YoY Change -27.32%
TOTAL ASSETS
Total Short-Term Assets $28.49K
Total Long-Term Assets $53.07M
Total Assets $53.10M
YoY Change -27.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $346.2K
YoY Change 394.59%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $879.2K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.305M
YoY Change 1613.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.305M
Total Long-Term Liabilities $0.00
Total Liabilities $1.305M
YoY Change 1531.52%
SHAREHOLDERS EQUITY
Retained Earnings -$1.277M
YoY Change -4492.96%
Common Stock $228.00
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.277M
YoY Change
Total Liabilities & Shareholders Equity $53.10M
YoY Change -27.38%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $502.0K
YoY Change -33.59%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$6.700K
YoY Change -95.81%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$220.0K
YoY Change
Cash From Investing Activities -$220.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 220.0K
YoY Change
NET CHANGE
Cash From Operating Activities -6.700K
Cash From Investing Activities -220.0K
Cash From Financing Activities 220.0K
Net Change In Cash -6.700K
YoY Change -95.81%
FREE CASH FLOW
Cash From Operating Activities -$6.700K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2023Q4 us-gaap Liabilities
Liabilities
387955 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
50880604 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
228 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-325050 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-324822 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50943737 usd
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
198821 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
566903 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-182580 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001937891
CY2023Q4 us-gaap Escrow Deposit
EscrowDeposit
usd
CY2024Q3 us-gaap Escrow Deposit
EscrowDeposit
55000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9837 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9837 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
487194 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-198821 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-566903 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-487194 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
954788 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1893221 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
2592461 usd
CY2023Q3 us-gaap Interest Income Other
InterestIncomeOther
21 usd
us-gaap Interest Income Other
InterestIncomeOther
6 usd
us-gaap Interest Income Other
InterestIncomeOther
175 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
954809 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1800911 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2592636 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
755988 usd
us-gaap Net Income Loss
NetIncomeLoss
1234008 usd
us-gaap Net Income Loss
NetIncomeLoss
2105442 usd
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2024Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
usd
CY2023Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
usd
us-gaap Increase Decrease In Notes Payable Related Parties Current
IncreaseDecreaseInNotesPayableRelatedPartiesCurrent
usd
ATMV Payment Cash Deposited To Trust Account
PaymentCashDepositedToTrustAccount
usd
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
ATMV Accrued Expenses Converted To Promissory Note To Related Party
AccruedExpensesConvertedToPromissoryNoteToRelatedParty
usd
ATMV Accrued Expenses Converted To Promissory Note To Third Party
AccruedExpensesConvertedToPromissoryNoteToThirdParty
usd
ATMV Prepaid Expenses Paid By Promissory Note To Third Party
PrepaidExpensesPaidByPromissoryNoteToThirdParty
usd
CY2023Q3 ATMV Accretion Expense Extension Deposit
AccretionExpenseExtensionDeposit
usd
ATMV Accretion Expense Extension Deposit
AccretionExpenseExtensionDeposit
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41574
dei Entity Registrant Name
EntityRegistrantName
ALPHAVEST ACQUISITION CORP
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Address Address Line1
EntityAddressAddressLine1
205 W 37th St
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10018
dei City Area Code
CityAreaCode
203
dei Local Phone Number
LocalPhoneNumber
998-5540
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7006329 shares
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.0001
CY2024Q3 us-gaap Cash
Cash
7095 usd
CY2023Q4 us-gaap Cash
Cash
28560 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
21399 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
34573 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
28494 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
63133 usd
CY2024Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
53011509 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
50880604 usd
CY2024Q3 us-gaap Assets
Assets
53095003 usd
CY2023Q4 us-gaap Assets
Assets
50943737 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
346209 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
213118 usd
CY2024Q3 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
70000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1305213 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
387955 usd
CY2024Q3 us-gaap Liabilities
Liabilities
1305213 usd
CY2024Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
4725829 shares
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
4725829 shares
CY2024Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
11.23
CY2023Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.77
CY2024Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
53066509 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2280500 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2280500 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2280500 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2280500 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
228 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1276947 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-1276719 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53095003 usd
CY2024Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
182580 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
684600 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-92316 usd
CY2024Q3 us-gaap Interest Income Other
InterestIncomeOther
1 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
684601 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
502021 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
554543 usd
CY2023Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-841220 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
644898 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
358221 usd
CY2023Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-834681 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
704556 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
228096 usd
CY2023Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-954788 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
755988 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
29296 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-324822 usd
CY2024Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-586164 usd
CY2024Q1 ATMV Stock Redeemed Or Called During Period Value One
StockRedeemedOrCalledDuringPeriodValueOne
-55000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
349241 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-616745 usd
CY2024Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-530141 usd
CY2024Q2 ATMV Stock Redeemed Or Called During Period Value One
StockRedeemedOrCalledDuringPeriodValueOne
-110000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
382746 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-874140 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-874140 usd
CY2024Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-684600 usd
CY2024Q3 ATMV Stock Redeemed Or Called During Period Value One
StockRedeemedOrCalledDuringPeriodValueOne
-220000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
502021 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-1276719 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-1276719 usd
us-gaap Net Income Loss
NetIncomeLoss
1234008 usd
us-gaap Net Income Loss
NetIncomeLoss
2105442 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1893221 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
2592461 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-92316 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-94174 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-67530 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
366677 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-181703 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
70000 usd
us-gaap Increase Decrease In Notes Payable Related Parties Current
IncreaseDecreaseInNotesPayableRelatedPartiesCurrent
14580 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21465 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-601192 usd
ATMV Payment Cash Deposited To Trust Account
PaymentCashDepositedToTrustAccount
330000 usd
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
55000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-385000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
55000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
330000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
385000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21465 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-601192 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28560 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
659035 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7095 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
57843 usd
us-gaap Stock Issued1
StockIssued1
2185905 usd
us-gaap Stock Issued1
StockIssued1
2630689 usd
ATMV Accrued Expenses Converted To Promissory Note To Related Party
AccruedExpensesConvertedToPromissoryNoteToRelatedParty
188587 usd
ATMV Accrued Expenses Converted To Promissory Note To Third Party
AccruedExpensesConvertedToPromissoryNoteToThirdParty
45000 usd
ATMV Prepaid Expenses Paid By Promissory Note To Third Party
PrepaidExpensesPaidByPromissoryNoteToThirdParty
81000 usd
CY2022Q4 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
61200000 usd
CY2022Q4 ATMV Cash Deposited In Trust Account Per Unit
CashDepositedInTrustAccountPerUnit
10.20
ATMV Percentage Of Public Shares That Would Not Be Redeemed If Business Combination Is Not Completed Within Initial Combination Period
PercentageOfPublicSharesThatWouldNotBeRedeemedIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod
1 pure
CY2024Q3 us-gaap Liquidation Basis Of Accounting Accrued Costs To Dispose Of Assets And Liabilities
LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities
100000 usd
CY2023Q4 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
2174171 shares
CY2023Q4 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
23282936 usd
CY2023Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.71
CY2024Q3 us-gaap Cash
Cash
7095 usd
CY2024Q3 ATMV Working Capital Deficit
WorkingCapitalDeficit
1276719 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_z7G4SGWC8y9j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_z7qXyT4BqQ32">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7095 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28560 usd
CY2024Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
53011509 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
50880604 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
684600 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
954788 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1893221 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
2592461 usd
CY2024Q3 ATMV Cash Held In Trust Escrow Account Not Yet Deposited
CashHeldInTrustEscrowAccountNotYetDeposited
55000 usd
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2024Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
502021 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
755988 usd
us-gaap Net Income Loss
NetIncomeLoss
1234008 usd
us-gaap Net Income Loss
NetIncomeLoss
2105442 usd
CY2024Q3 us-gaap Accretion Expense
AccretionExpense
684600 usd
CY2023Q3 us-gaap Accretion Expense
AccretionExpense
954788 usd
us-gaap Accretion Expense
AccretionExpense
1800904 usd
us-gaap Accretion Expense
AccretionExpense
2630689 usd
CY2024Q3 ATMV Accretion Expense Extension Deposit
AccretionExpenseExtensionDeposit
220000 usd
ATMV Accretion Expense Extension Deposit
AccretionExpenseExtensionDeposit
385000 usd
CY2024Q3 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
-402579 usd
CY2023Q3 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
-198800 usd
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
-951896 usd
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
-525247 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zwWP6FyKLAU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zXo81VU3i844">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_909_eus-gaap--CashFDICInsuredAmount_iI_c20240930_zJ2wA3MG4ER3" title="Federal Depository Insurance Coverage">250,000</span>. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
50880604 usd
CY2024Q1 ATMV Stock Issued During Period Value For Common Stock Subject To Redemption Amount Investment Held In Trust Account
StockIssuedDuringPeriodValueForCommonStockSubjectToRedemptionAmountInvestmentHeldInTrustAccount
586164 usd
CY2024Q1 ATMV Stock Issued During Period Value For Common Stock Subject To Redemption Amount Extension Deposit
StockIssuedDuringPeriodValueForCommonStockSubjectToRedemptionAmountExtensionDeposit
55000 usd
CY2024Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
51521768 usd
CY2024Q2 ATMV Stock Issued During Period Value For Common Stock Subject To Redemption Amount Investment Held In Trust Account
StockIssuedDuringPeriodValueForCommonStockSubjectToRedemptionAmountInvestmentHeldInTrustAccount
530141 usd
CY2024Q2 ATMV Stock Issued During Period Value For Common Stock Subject To Redemption Amount Extension Deposit
StockIssuedDuringPeriodValueForCommonStockSubjectToRedemptionAmountExtensionDeposit
110000 usd
CY2024Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
52161909 usd
CY2024Q3 ATMV Stock Issued During Period Value For Common Stock Subject To Redemption Amount Investment Held In Trust Account
StockIssuedDuringPeriodValueForCommonStockSubjectToRedemptionAmountInvestmentHeldInTrustAccount
684600 usd
CY2024Q3 ATMV Stock Issued During Period Value For Common Stock Subject To Redemption Amount Extension Deposit
StockIssuedDuringPeriodValueForCommonStockSubjectToRedemptionAmountExtensionDeposit
220000 usd
CY2024Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
53066509 usd
CY2024Q3 us-gaap Other Liabilities
OtherLiabilities
433004 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
174837 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
30000 usd
us-gaap Professional Fees
ProfessionalFees
90000 usd
CY2024Q3 ATMV Administrative Expense Outstanding
AdministrativeExpenseOutstanding
103871 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
30000 usd
us-gaap Professional Fees
ProfessionalFees
90000 usd
CY2022Q2 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
150000 usd
CY2024Q3 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
0 usd
CY2023Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
0 usd
CY2024Q1 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
537 usd
CY2023Q1 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
784 usd
CY2024Q3 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
134 usd
CY2023Q3 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
198 usd
us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
425 usd
us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
436 usd
CY2022Q4 us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
1725000 usd
ATMV Percentage Of Cash Fee On Consideration Payable In Initial Business Combination
PercentageOfCashFeeOnConsiderationPayableInInitialBusinessCombination
0.010 pure
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2280500 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2280500 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2280500 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2280500 shares
CY2024Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
4725829 shares
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
4725829 shares
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
92316 usd

Files In Submission

Name View Source Status
0001493152-24-046848-index-headers.html Edgar Link pending
0001493152-24-046848-index.html Edgar Link pending
0001493152-24-046848.txt Edgar Link pending
0001493152-24-046848-xbrl.zip Edgar Link pending
atmv-20240930.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
atmv-20240930_cal.xml Edgar Link unprocessable
atmv-20240930_lab.xml Edgar Link unprocessable
atmv-20240930_def.xml Edgar Link unprocessable
atmv-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed